APX005M and Doxorubicin in Advanced Sarcoma | MicrobiomeTrials← Back to trialsNCT03719430
APX005M and Doxorubicin in Advanced Sarcoma
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2019-03-20Est. Completion: 2025-12-11
Enrollment target: 27 participants Locations- City of Hope, Duarte, California, United States
- Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
- Columbia University Irving Medical Center/NYP, New York, New York, United States
Other microbiome trials you might be interested in
DLBCL - Diffuse Large B Cell Lymphoma
This study will ultimately aim at providing the scientific community with patient-reported health status data that will …
Bologna, ItalyCompleted Feb 15, 2024
Gastro-Oesophageal Cancer
To determine if the regorafenib and nivolumab combination (RegoNivo) improves overall survival compared with current sta…
Scottsdale, United StatesCompleted Jan 14, 2025
Recruiting
Lung CancerLung Cancer (NSCLC)Locally Advanced NSCLCMetastatic NSCLC - Non-Small Cell Lung Cancer
This clinical trial evaluates the combination of olomorasib and pembrolizumab as a first-line treatment for patients wit…
Chapel Hill, United StatesEst. completion Jun 21, 2030